ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,833Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1269

$1.01M Total Retail Price of All Prescriptions

Rank: 27 out of 1269

449 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 449 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 7,143 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 426 256 1 2
METFORMIN HCL 401 193 2 9
LEVOTHYROXINE SODIUM 344 191 3 4
LISINOPRIL 344 180 3 1
SIMVASTATIN 343 200 5 3
METOPROLOL TARTRATE 337 211 6 6
BENZTROPINE MESYLATE 311 62 R 7 108
OMEPRAZOLE 305 154 8 8
PRAVASTATIN SODIUM 285 177 9 11
DIVALPROEX SODIUM 276 65 10 54
TRAMADOL HCL 221 114 11 16
TRAZODONE HCL 216 107 12 36
RANITIDINE HCL 206 92 13 27
RISPERIDONE 197 85 14 43
METOPROLOL SUCCINATE 191 127 15 13
OLANZAPINE 172 21 16 89
ATORVASTATIN CALCIUM 158 80 17 7
DONEPEZIL HCL 158 111 17 22
QUETIAPINE FUMARATE 155 77 19 53
MIRTAZAPINE 154 64 20 24
FUROSEMIDE 146 119 21 5
ZOLPIDEM TARTRATE 144 86 22 19
LOSARTAN POTASSIUM 134 101 23 15
CLOZAPINE 129 24 24 185
PANTOPRAZOLE SODIUM 126 64 25 18
FLUTICASONE PROPIONATE 124 64 26 40
LOSARTAN-HYDROCHLOROTHIAZIDE 119 89 27 59
CITALOPRAM HBR 116 40 28 21
SERTRALINE HCL 112 71 29 23
NEXIUM 108 32 30 41
TAMSULOSIN HCL 108 41 30 31
HYDROCHLOROTHIAZIDE 107 62 32 10
OXCARBAZEPINE 102 48 33 213
LAMOTRIGINE 99 35 34 194
HALOPERIDOL 92 0 35 133
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 65 35 33
ACTOS 91 52 37 161
ADVAIR DISKUS 91 40 37 46
LITHIUM CARBONATE 85 11 39 285
ALENDRONATE SODIUM 85 48 39 28
DIVALPROEX SODIUM ER 82 25 41 176
PHENYTOIN SODIUM EXTENDED 80 37 42 137
DIOVAN HCT 79 41 43 76
POTASSIUM CHLORIDE 79 54 43 26
WARFARIN SODIUM 78 42 45 12
LEVETIRACETAM 78 36 45 55
FLUOXETINE HCL 77 18 47 83
ABILIFY 76 25 48 169
HYDROCODONE-ACETAMINOPHEN 75 17 S3 49 20
CLONIDINE HCL 75 67 49 51
LANTUS 74 30 51 39
INSULIN SYRINGE 74 26 51 87
ATENOLOL 73 71 53 14
IBUPROFEN 72 21 54 73
LACTULOSE 72 54 54 67
CARBAMAZEPINE 72 0 54 148
DIOVAN 70 54 57 35
POLYETHYLENE GLYCOL 3350 70 34 57 50
GABAPENTIN 69 25 59 17
FLUPHENAZINE HCL 68 19 60 282
SEROQUEL 66 26 61 104
VESICARE 63 39 62 241
OXYBUTYNIN CHLORIDE 61 33 63 128
LIPITOR 59 40 64 91
LYRICA 59 27 64 92
NIFEDIPINE ER 58 43 66 65
PLAVIX 58 41 66 47
CARVEDILOL 57 39 68 29
PROAIR HFA 54 33 69 61
ISOSORBIDE MONONITRATE ER 52 37 70 63
MELOXICAM 52 32 70 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.